CardioCampus

The CCS is pleased to announce the launch of the fourth edition of the CCS annual program, Hypertrophic Cardiomyopathy Learning Series 4.0. This year’s program will continue to advance education in Hypertrophic Cardiomyopathy (HCM) by addressing critical gaps in diagnosis, treatment, and long-term management. Building on the success of previous years, the series is designed to further enhance the knowledge and clinical practices of healthcare professionals managing HCM across Canada.

Tailored to address the distinct healthcare challenges within each region, the series will consist of four MOC Section 1 accredited webinars that will cover: Atlantic Canada (in June), Quebec, Ontario and Western Canada. Each session will feature interactive, case-based learning modules designed to enhance practical understanding. The planning committee will select compelling cases that address learning gaps identified through participant feedback as well as new advancements and Canadian treatment options.

Do you have a complex or challenging case that could spark meaningful discussion? We invite you to submit it for consideration. Selected cases will be featured during one of our four sessions. Click here to submit your cases. 

Program Chair and Moderator: Dr. Anil Gupta

Presenters: Dr. Andrew Moeller, Dr. David Bewick, and Dr. Kim Anderson

Learning Objectives: 

• Identify and address diagnostic and therapeutic challenges in obstructive HCM across Atlantic Canada.  

• Apply evidence-based strategies for managing obstructive HCM.  

• Understand regional variations in treatment access and care delivery.  

• Strengthen interdisciplinary collaboration in HCM care.